簡體中文Olopatadine hydrochloride tablets has been approved by China SF
Release time：2021-12-12
Our new formulation Olopatadine hydrochloride tablets (5mg ) has been approved by China SFDA on 31st May 2022. The tablets registration certificate No. is H20213892 and H20223350.
Reprint statement: reprint please indicate "source: Wista pharma".
Back
Voriconazole tablets has been approved by China SF
86-10-67887855
Head Office：
Marketing：
Wista Pharmam